A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

NCT07733765 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Ritlecitinib 100 mg
DRUG: Ritlecitinib 50 mg
OTHER: Placebo

Sponsor

Pfizer